menu

Evidence & Value

Healthcare costs are climbing, regulators around the globe are requiring more information, and both providers and payers have higher expectations for a medical treatment’s proof of value before prescribing or paying for those treatments.

promo_digital_graphs
Featured Video

Quintiles Blog

Fresh ideas and insights from our experts around the globe

Blog

Quintiles Authors

Senior Vice President, Advisory Services

Senior Vice President, Advisory Services

Peer-Reviewed Publications

Did you know...

“Efficacy” is the top definition of value for US payers.
US providers most often define value as “improved quality of life.”
“Addressing unmet medical need” is biopharma’s top definition of value.